[Webinar] Integrating animals, assays and therapeutics to simplify in vivo study management
How pharma firms can escape in vivo data chaos and gain a competitive advantage by digitalizing their labs
Join this webinar to find out how the digitalized lab of the future will integrate all aspects of the drug discovery pipeline to bring therapeutics to market faster
With methods used to manage in vivo studies becoming obsolete and return on investment for drug discovery R&D steadily declining, Julie Morrison, President of RockStep Solutions, and Steve Manning, Head of North American Biologics at Dotmatics, will reveal how the partnership between their organizations has led to the introduction of an integrated digitalized solution for end-to-end in vivo drug discovery.
By digitalizing drug discovery pharma organizations can enhance cross-departmental integration and enable researchers to search data upstream and downstream, with visibility into their operations and chain of custody, as well as helping bring therapeutics to market faster.
This webinar will explain why the digitalized lab of the future will ensure all aspects of the discovery and safety pipeline are accessible to authorized personnel on demand, as well as how a single, federated search capacity can be utilized to increase research output without researchers wasting their time in data silos. The session will also demonstrate why a cloud-based system can future-proof discovery and safety operations by ensuring the latest security and technology is deployed, while also preparing users for automation and artificial intelligence integration.
Join this webinar to find out:
- Why global collaboration requires on-demand access to optimize efforts and research output
- How to reduce data silos to provide a single, federated search capability
- What the benefits are of a comprehensive, out-of-the-box solution for digital drug discovery
- Digitalizing your lab does not have to be a long, complicated undertaking – it is easier than you think
Presenters
Sponsor